XOMA Royalty Significantly Expands Its Royalty and Milestone Portfolio With the Addition of Over 60 Early-Stage Programs From Twist Bioscience

GlobeNewswireOct 22 08:00 ET

XOMA CORP 8.625% CUM PERP PFD SER A To Go Ex-Dividend On October 3rd, 2024 With 0.53906 USD Dividend Per Share

Moomoo NewsSep 23 19:40 ET

Zevra's MIPLYFFA (Arimoclomol) Receives Approval From U.S. Food and Drug Administration for Use in Patients With Niemann-Pick Disease Type C (NPC)

GlobeNewswireSep 23 06:30 ET

XOMA Royalty to Present at Upcoming Investor Conferences in September

GlobeNewswireSep 4 07:30 ET

10-Q: Q2 2024 Earnings Report

SECAug 13 07:42 ET · Announcements

XOMA CORP 8.625% CUM PERP PFD SER A To Go Ex-Dividend On July 3rd, 2024 With 0.53906 USD Dividend Per Share

Moomoo NewsJun 20 19:40 ET